Janon, Sendoy .
HRN: 22-39-72 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/07/2023
OXACILLIN 500MG (VIAL)
09/07/2023
09/13/2023
IVT
175mg
Q6hrs
Bacterial Skin Infection; Pcap C
Waiting Final Action
Indication: Empiric Type of Infection: PneumoniaSkin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes